31st October 2024 – Buckinghamshire, UK
Radcliffe Group announces that Interventional Cardiology Review, Research, Resources (ICR3), official journal of the British Cardiovascular Intervention Society (BCIS), had been awarded a Journal Impact Factor™ of 2.5.
ICR3's achievement of a Journal Impact Factor™ underscores its position as a leading resource for clinicians seeking the latest advancements in research in interventional cardiology.
On news of achieving the Journal Impact Factor™, ICR3 Editor-in-Chief Dr Peter O’Kane (pictured) commented, “I am thrilled that ICR3 has received its first impact factor of 2.5. I congratulate the editorial team at Radcliffe and thank both authors and expert reviewers who have contributed to this successful announcement. I am confident we can further develop the academic impact of this journal which aims to showcase contemporary reviews, research and provide efficient and effective resources to clinicians across the world working in interventional cardiology.”
Of the announcement, David Ramsey, CEO of Radcliffe Group commented, "This is a significant milestone for ICR3. The journal's continued success is a testament to the high-quality research being published. We're committed to serving our expanding global audience of interventional cardiologists and thank everyone who has contributed to our journey.”
The Radcliffe team extends its deepest gratitude to the Editor-in-Chief, Dr Peter O’Kane, and Deputy Editors, Dr John Rawlins and Dr Giuseppe Ando for their leadership. We also recognise the invaluable contributions of hundreds of expert authors and our ever-growing readership.
About Interventional Cardiology Review, Research, Resources
ICR3 is an international, English-language, peer-reviewed journal that publishes articles continuously on icrjournal.com. The journal comprises balanced and comprehensive review articles to provide updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.